Søgeresultater - Yuejuan Cheng

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Response to trastuzumab deruxtecan and delayed immune-related events in a patient with metastatic HER2-positive NSCLC: a case report and literature review

    Response to trastuzumab deruxtecan and delayed immune-related events in a patient with metastatic HER2-positive NSCLC: a case report and literature review af Lu Wang, Shidi Wen, Wenjia Zhu, Zhiyang Zhang, Yuejuan Cheng

    Udgivet 2025
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Complete Genome Sequence of Industrial Biocontrol Strain Paenibacillus polymyxa HY96-2 and Further Analysis of Its Biocontrol Mechanism

    Complete Genome Sequence of Industrial Biocontrol Strain Paenibacillus polymyxa HY96-2 and Further Analysis of Its Biocontrol Mechanism af Yuanchan Luo, Yuejuan Cheng, Jincui Yi, Zhi‐Jun Zhang, Qian Luo, Daojing Zhang, Yuanguang Li

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog <sup>177</sup>Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors

    Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog <sup>177</sup>Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors af Jingjing Zhang, Hao Wang, Orit Jacobson, Yuejuan Cheng, Gang Niu, Fang Li, Chunmei Bai, Zhaohui Zhu, Xiaohong Chen

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Head-to-Head Comparison of <sup>68</sup>Ga-DOTA-JR11 and <sup>68</sup>Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: A Prospective Study

    Head-to-Head Comparison of <sup>68</sup>Ga-DOTA-JR11 and <sup>68</sup>Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: A Prospective Study af Wenjia Zhu, Yuejuan Cheng, Xuezhu Wang, Shaobo Yao, Chunmei Bai, Hong Zhao, Ru Jia, Jianming Xu, Li Huo

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial

    Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial af Jian-Ming Xu, Jie Li, Chunmei Bai, Nong Xu, Zhiwei Zhou, Zhiping Li, Caicun Zhou, Ru Jia, Ming Lu, Yuejuan Cheng, Chenyu Mao, Wei Wang, Ke Cheng, Chunxia Su, Hua Ye, Chuan Qi, Jing Li, Wei Wang, Ke Li, Qiaoling Sun, Yongxin Ren, Weiguo Su

    Udgivet 2019
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: